`

Evofem Biosciences

Biotechnology Research

revenue-icon Revenue
1B+
funding-icon Total Funding
$26.6M
size-icon Size
11 - 50

Frequently Asked Questions About Evofem Biosciences

What does Evofem biosciences do?+

Evofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in womens sexual and reproductive health. In September 2020, Evofem launched Phexxi, the first and only hormone-free, on-demand, prescription birth control available in the U.S. that women use only when they have sex. In July 2024, Evofem acquired SOLOSEC, an FDA-approved single-dose oral antimicrobial agent for the treatment of two common sexual health infections: trichomoniasis and bacterial vaginosis

What is Evofem biosciences's industry? +

Evofem biosciences operates in the Biotechnology research industry.

What is Evofem biosciences's revenue? +

Evofem biosciences's revenue is 1b+

What is Evofem biosciences's company size? +

Evofem biosciences has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.